COR Cencora Inc.
725
$222.12
$0.27
(0.12%)
| Watchers | 725 |
| 52-Wk Low | $163.37 |
| 52-Wk High | $246.75 |
| Market Cap | $44.3B |
| Volume | 1M |
| 52-Wk High | $246.75 |
| 52-Wk Low | $163.37 |
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth TodayBenzinga • 2 days ago
read more...
Share to Feed
Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent year-over-year to $68.4 billion. On the basis of U.S...
Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2024 on Wednesday, May 1, 2024, prior to the opening of trading on the New York Stock...
TimesSquare Capital Management, an equity investment management company, released its U.S. Mid Cap Growth Strategy fourth-quarter investor letter. A copy of the same can be downloaded here. In the...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service...
Teladoc Health, Inc. TDOC is well-poised to grow on the back of rising access fees and the continuous adoption of telehealth services. Its expanding product offerings are likely to bring in more...
Shares of McKesson Corporation MCK scaled a new 52-week high of $539.99 on Mar 27, 2024, before closing the session marginally lower at $539.26.Over the past year, this Zacks Rank #3 (Hold) stock has...
Walgreens Boots Alliance, Inc. WBA delivered adjusted earnings per share (EPS) of $1.20 in second-quarter fiscal 2024, surging 3.4% from the year-ago quarter’s figure (up 2.8% at constant...
GE HealthCare Technologies Inc. GEHC recently announced the launch of the Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature.This AI-powered software function...
Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2023...